Jacobs Levy Equity Management, Inc Seagen Inc. Transaction History

Jacobs Levy Equity Management, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $317,251 - $376,176	-2,703 Reduced 3.67%	70,972 $9.12 Million
Q3 2022 Nov 15, 2022	BUY	$135.27 - $180.11 $9.97 Million - $13.3 Million	73,675 New	73,675 $10.1 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $160,516 - $211,834	-1,342 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $191,328 - $256,134	1,342 New	1,342 $207,000
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $7.35 Million - $10.2 Million	-53,435 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $8.8 Million - $11.3 Million	53,435 New	53,435 $9.36 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.